Paytient expands prescription benefit platform with GoodRx and Cost Plus Drugs
New offering combines prescription savings with interest-free payments to improve adherence and reduce employer healthcare costs.
Mark Cuban Cost Plus Drug Co.
Bristol Myers Squibb and Pfizer to make Eliquis (apixaban) available via Mark Cuban Cost Plus Drug Co.
Expands options for cash-paying patients to access the nation’s No. 1 prescribed oral blood thinner
Mark Cuban Cost Plus Drug Co. expands access with addition of Starjemza
New biosimilar added to portfolio reinforces the company's commitment to transparency and access.